Prospective multicEntric NonranDomized Registry
NCT02496169 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400
Last updated 2015-07-14
Summary
The purpose of this study is to evaluate the safety and efficacy of the eucaLimus Sirolimus Eluting stent system in patients with de novo coronary lesions.
Conditions
Interventions
- DEVICE
-
eucaLimus
Percutaneous Coronary Intervention (PCI)
Sponsors & Collaborators
-
CERES GmbH
collaborator INDUSTRY -
Eucatech AG
lead INDUSTRY
Principal Investigators
-
Jean-Marc Pernes, Dr. · Hôpital privé d' Antony 1 rue Velpeau 92160 Antony, France
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2016-12-31
- Completion
- 2017-12-31
More Related Trials
-
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)
NCT01078038 ·Status: COMPLETED ·Phase: PHASE4
-
Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting
NCT00960648 ·Status: COMPLETED
-
EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease
NCT01310309 ·Status: COMPLETED
-
Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents
NCT01073111 ·Status: WITHDRAWN ·Phase: NA
-
Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction
NCT02890589 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)
NCT01350869 ·Status: COMPLETED
-
Procedural Advantages of a Novel Drug-Eluting Coronary Stent
NCT02881216 ·Status: COMPLETED ·Phase: NA
-
Angiolite Registry Study
NCT07004569 ·Status: RECRUITING
-
Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents
NCT00598715 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
NCT07190690 ·Status: RECRUITING ·Phase: NA
-
COMPARE-II- Vasomotion and Imaging Substudy
NCT01329237 ·Status: UNKNOWN ·Phase: PHASE4
-
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
NCT02579031 ·Status: COMPLETED ·Phase: NA
-
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
NCT01443104 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions
NCT02542007 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent
NCT01233453 ·Status: UNKNOWN ·Phase: PHASE4
-
Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent
NCT00793221 ·Status: COMPLETED ·Phase: PHASE3
-
Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents
NCT01068106 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus
NCT00997763 ·Status: COMPLETED ·Phase: PHASE4
-
Everolimus- Versus Biolimus-Eluting Stents in All-Comers
NCT01472705 ·Status: COMPLETED
-
Prospective Registry to Asses the Long-term Safety and Performance of the Combo Stent
NCT01874002 ·Status: UNKNOWN
-
Clinical Investigation for Everolimus Drug Eluting Stent
NCT06769217 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)
NCT06086496 ·Status: ENROLLING_BY_INVITATION
-
A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI
NCT03440801 ·Status: COMPLETED ·Phase: NA
-
Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques
NCT00916695 ·Status: UNKNOWN ·Phase: PHASE4
-
International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions
NCT01373502 ·Status: COMPLETED ·Phase: NA